Procalcitonin as a precise biomarker of aging process
- Summary
- This invention shows daily aging process of all people. This invention helps "Longevity" of all people, suffering from the aging at all around the world. Blood level of procalcitonin shows daily aging process in 24 hours period of a day
- Detailed Technology Description
- This invention uses rapid or automatic test device for Diagnosis of daily procalcitonin level
- Type of Cooperation
- License agreement
- Supplementary Information
- Patent Number: US20130252254A1
Application Number: US13506278A
Inventor: Soylemez, Mehmet Ali
Priority Date: 21 Mar 2012
Priority Number: US20130252254A1
Application Date: 9 Apr 2012
Publication Date: 26 Sep 2013
IPC Current: G01N0033566 | C12M000134 | G01N002164 | G01N0033573
US Class: 4350074 | 422069 | 4352872 | 436501
Title: Procalcitonin gene expression as a precise biomarker of aging process
Usefulness: Procalcitonin gene expression as a precise biomarker of aging process
Summary: The method, kit and device are useful for in-vitro diagnosis and/or complications and/or risk stratification of aging process, and its sequelae and concomitant illnesses and cardiovascular complications, and for stratification of patients for clinical decisions related to treatment or therapy of aging and/or complications, prognosis and prophylaxis of the aging process, assessment of degree of severity, course of aging, preferably aging process and its concomitant illnesses and sequelae as an accompaniment to therapy (all claimed).
- Industry
- Biomedical
- Sub Category
- DNA/Gene Engineering
- Application No.
- US20130252254
- Coverage Areas
- US
- Patent Information
- Status: Patent Application
- Country/Region
- Turkiye
For more information, please click Here
